Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer-Reference-Cited by-同舟云学术

Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer

Published:2015-07-29 Issue:3 Volume:22 Page:644-656
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Arqués Oriol,Chicote Irene,Puig Isabel,Tenbaum Stephan P.,Argilés Guillem,Dienstmann Rodrigo,Fernández Natalia,Caratù Ginevra,Matito Judit,Silberschmidt Daniel,Rodon Jordi,Landolfi Stefania,Prat Aleix,Espín Eloy,Charco Ramón,Nuciforo Paolo,Vivancos Ana,Shao Wenlin,Tabernero Josep,Palmer Héctor G.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1α,25-hydroxyvitamin D/VDR suppresses stem-like properties of ovarian cancer cells by restraining nuclear translocation of β-catenin;Steroids;2024-11

2. Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors;Biochemical and Biophysical Research Communications;2024-10

3. HOTAIR Promotes the Hyperactivation of PI3K/Akt and Wnt/β-Catenin Signaling Pathways via PTEN Hypermethylation in Cervical Cancer;Cells;2024-09-04

4. PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways;Experimental & Molecular Medicine;2024-07-01

5. Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers;Cells;2024-06-19